Date: 31.8.2015
Summary: | |
A university spin-off SME in northern Sweden offers a new pre-clinical model for testing new anti-fibrotic and anti-inflammatory drugs. The new model shortens and simplifies the tests, lowering the cost and performs considerably better than the ones existing today. The SME is looking for partners that develop anti-fibrotic drugs or anti-inflammatory drugs, enabling them to do the testing more efficiently. The SME offers licensing of the entire concept and/or delivering test services. | |
Reference: | TOSE20150427001 |
Country: | Sweden |
Submitted: | Apr 27 2015 |
Updated: | Jul 10 2015 |
View Partnering Opportunity | |
KEYWORDS | |
Market: | Cellular and Molecular Biology, Genetic Engineering , Molecular design , Other Genetic Engineering |
Technology: | Clinical Research, Trials, Genetic Engineering |
NACE: | Research and experimental development on biotechnology |
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
DNA - Deoxyribonucleic acid (DNA) at Wikipedia
Life Sciences Search engine - Huge database of genome, protein, gene, genome project, ..
Bacteria-virus arms race provides rare window into rapid and complex evolution
Fluorous lipopeptides act as highly effective antibiotics for multidrug-resistant pathogens